Avallon Pharma secures 104M Riyal Credit from BSF
Avlon Pharma announced the renewal of an Islamic credit facility agreement valued at 104 million Riyals with French Saudi Bank, for a one-year period starting September 17, 2026. The purpose of the facility is to finance working capital and support operational activities. The guarantee includes promissory notes to secure the bank's rights and enhance the liquidity necessary to cover daily expenses, purchase raw materials, and manage inventory. The company also indicated that there are no related-party relationships involved in the transaction, reflecting mutual trust between the company and the bank, and reaffirming its commitment to the applicable financial regulations in Saudi Arabia.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)